Blue Bird Corp
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.2% | +5.8% | +2.5% | +12.1% | +2.0% | +1.6% | +5.8% | +8.7% | +2.7% | +7.3% | +69.2% | |
| – | +3.1% | +10.7% | +2.3% | +17.3% | +2.3% | -0.7% | +9.8% | +14.1% | +3.4% | +9.6% | +10.1% | |
| – | -2.1% | +20.4% | -5.0% | +44.4% | +6.6% | -3.9% | +32.4% | +32.5% | +5.4% | +14.1% | -57.7% | |
| – | -2.1% | +20.4% | -5.0% | +44.4% | +6.6% | -3.9% | +32.4% | +32.5% | +5.4% | +14.1% | -57.7% | |
| – | -11.7% | +2.9% | +197.6% | +73.8% | -76.3% | +12.8% | +33.7% | -2.2% | -47.9% | +20.2% | +313.4% | |
| – | +5.3% | +2.1% | -0.6% | -11.6% | +27.6% | +0.4% | -7.8% | -7.7% | +1.0% | +2.7% | +108.9% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +1,302.9% | |
| – | -1.0% | -1.0% | -1.0% | -1.1% | -1.1% | -1.1% | -1.1% | -1.1% | -1.1% | -1.1% | +331.5% | |
| – | -5.8% | -1.4% | -5.7% | +10.4% | -2.7% | -0.6% | +0.1% | +4.6% | +0.3% | +5.5% | +30.7% | |
| – | -18.2% | +17.0% | -10.1% | +19.4% | -2.8% | -1.2% | +0.9% | +3.6% | -0.7% | +8.2% | +23.2% | |
| – | -70.7% | -1.4% | +3.8% | -2.4% | -9.0% | -1.1% | -7.0% | +0.0% | +0.0% | +0.0% | +19.5% | |
| – | -16.9% | +21.9% | -7.7% | +11.7% | -3.8% | +11.6% | -2.3% | +0.9% | -19.7% | +4.5% | +37.6% | |
| – | +17.3% | -28.8% | -1.3% | -1.3% | -1.3% | -1.3% | -1.3% | -1.4% | -1.4% | -1.4% | -1.4% | |
| – | +89.0% | +40.0% | +29.8% | +16.2% | +12.6% | +5.9% | +16.5% | +15.1% | +6.2% | +9.8% | +119.8% | |
| – | – | – | – | -100.0% | – | +32.3% | +111.3% | +68.9% | +17.9% | +23.4% | +144.4% | |
| – | +0.2% | +2.0% | +1.8% | +0.2% | -1.1% | -1.4% | -0.9% | +0.8% | -0.7% | -0.2% | +8.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.